Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.36 |
| ▸ | CTSK | P43235 | 6/20 | 0.34 |
| ▸ | TLR4 | O00206 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3390529 | 1.00 | AR (0.36) | ARCTSKTLR4TLR2ALDH1A1 | |
| SCHEMBL3387267 | 0.99 | AR (0.36) | ARCTSKTLR4TLR2ALDH1A1 | |
| SCHEMBL3387272 | 0.99 | AR (0.36) | ARCTSKTLR4TLR2ALDH1A1 | |
| SCHEMBL1722332 | 0.81 | AR (0.42) | ARCTSKTLR4TLR2ALDH1A1 | |
| SCHEMBL13400236 | 0.79 | AR (0.41) | ARCTSKTLR4TLR2ALDH1A1 | |
| SCHEMBL13400308 | 0.76 | AR (0.38) | ARCTSKALDH1A1CRBNCTSL | |
| SCHEMBL13459306 | 0.76 | AR (0.40) | ARCRBN | |
| SCHEMBL13400246 | 0.76 | ALDH1A1 (0.40) | ARCTSKALDH1A1CTSL | |
| SCHEMBL3385460 | 0.75 | AR (0.38) | AR | |
| SCHEMBL3385464 | 0.75 | AR (0.38) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093865-A1 | SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ACUCELA, INC. (US) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093865-A1 | SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ALDH1A2, MPST, CLN6 | AR 4092/4885CTSK 2722/4885TLR4 947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.